RhumbLine Advisers’s Aegerion Pharmaceuticals, Inc. AEGR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q2 | – | Sell |
-26,314
| Closed | -$97K | – | 3070 |
|
|
2016
Q1 | $97K | Buy |
26,314
+100
| +0.4% | +$369 | ﹤0.01% | 2900 |
|
|
2015
Q4 | $265K | Buy |
26,214
+1,465
| +6% | +$14.8K | ﹤0.01% | 2651 |
|
|
2015
Q3 | $337K | Buy |
24,749
+111
| +0.5% | +$1.51K | ﹤0.01% | 2467 |
|
|
2015
Q2 | $467K | Sell |
24,638
-4,875
| -17% | -$92.4K | ﹤0.01% | 2379 |
|
|
2015
Q1 | $772K | Buy |
29,513
+4,000
| +16% | +$105K | ﹤0.01% | 2026 |
|
|
2014
Q4 | $534K | Sell |
25,513
-2,150
| -8% | -$45K | ﹤0.01% | 2237 |
|
|
2014
Q3 | $923K | Sell |
27,663
-310
| -1% | -$10.3K | ﹤0.01% | 1810 |
|
|
2014
Q2 | $898K | Sell |
27,973
-841
| -3% | -$27K | ﹤0.01% | 1899 |
|
|
2014
Q1 | $1.33M | Sell |
28,814
-1,410
| -5% | -$65K | ﹤0.01% | 1615 |
|
|
2013
Q4 | $2.15M | Sell |
30,224
-430
| -1% | -$30.5K | 0.01% | 1325 |
|
|
2013
Q3 | $2.63M | Buy |
30,654
+1,152
| +4% | +$98.7K | 0.01% | 1174 |
|
|
2013
Q2 | $1.87M | Buy |
+29,502
| New | +$1.87M | 0.01% | 1347 |
|